Anthracene-9-Carboxylic Acid

Anthracene-9-Carboxylic Acid

SCHEMBL6349231

O=C([O-])c1c2ccccc2cc2ccccc12.[Na+]

nearest known ligand 0.63

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Anthracene-9-Carboxylic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 known ✓ P00918 2/20 0.43
CA4 known ✓ P22748 2/20 0.43
CA1 known ✓ P00915 1/20 0.39
ALDH1A1 P00352 6/20 0.63
KDM4E B2RXH2 4/20 0.63
HPGD P15428 4/20 0.63
MEN1 O00255 3/20 0.63
KMT2A Q03164 3/20 0.63
HSD17B10 Q99714 2/20 0.63
CYP1A2 P05177 1/20 0.63
GLA P06280 1/20 0.63
CYP2C19 P33261 1/20 0.63
CYP3A4 P08684 1/20 0.45
BCHE P06276 1/20 0.45
ACHE P22303 1/20 0.45
GPR84 Q9NQS5 1/20 0.44
GPR35 Q9HC97 1/20 0.42
GAA P10253 1/20 0.41
MAPT P10636 1/20 0.40
TRPM4 Q8TD43 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Anthracene-9-Carboxylic Acid SCHEMBL4312810 0.96 ALDH1A1 (0.63) ALDH1A1KDM4EHPGDMEN1KMT2A
Anthracene-9-Carboxylic Acid SCHEMBL28354377 0.96 ALDH1A1 (0.63) ALDH1A1KDM4EHPGDMEN1KMT2A
Anthracene-9-Carboxylic Acid SCHEMBL11451382 0.96 ALDH1A1 (0.63) ALDH1A1KDM4EHPGDMEN1KMT2A
Anthracene-9-Carboxylic Acid SCHEMBL11788259 0.96 ALDH1A1 (0.63) ALDH1A1KDM4EHPGDMEN1KMT2A
SCHEMBL846868 0.80 ALDH1A1 (0.50) ALDH1A1KDM4EHPGDMEN1KMT2A
Lithium Ion SCHEMBL10417203 0.80 ALDH1A1 (0.50) ALDH1A1KDM4EHPGDMEN1KMT2A
SCHEMBL30109015 0.80 ALDH1A1 (0.50) ALDH1A1KDM4EHPGDMEN1KMT2A
SCHEMBL30108944 0.80 ALDH1A1 (0.50) ALDH1A1KDM4EHPGDMEN1KMT2A
SCHEMBL30108874 0.80 ALDH1A1 (0.50) ALDH1A1KDM4EHPGDMEN1KMT2A
SCHEMBL30108986 0.80 ALDH1A1 (0.50) ALDH1A1KDM4EHPGDMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113967450-B Bioactive hydrogel with photon up-conversion function and preparation method and application thereof 中国科学院理化技术研究所 2024-04-12 CN claimed
CN-113967450-A Bioactive hydrogel with photon up-conversion function and preparation method and application thereof 中国科学院理化技术研究所 2022-01-25 CN claimed
CN-113967450-B Bioactive hydrogel with photon up-conversion function and preparation method and application thereof 中国科学院理化技术研究所 2024-04-12 CN disclosed
CN-113967450-A Bioactive hydrogel with photon up-conversion function and preparation method and application thereof 中国科学院理化技术研究所 2022-01-25 CN disclosed
US-6924375-B2 Facile synthesis of 1,9-diacyldipyrromethanes NORTH CAROLINA STATE UNIVERSITY (US) 2005-08-02 US disclosed
US-20050054858-A1 Facile synthesis of 1,9-diacyldipyrromethanes NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR 2005-03-10 US disclosed
EP-0138627-A2 Energy transfer agents COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) 1985-04-24 EP disclosed
US-4460723-A STABILIZATION WITH ACID SALTS ALONE AND WITH RUBBER ADDITIONS PHILLIPS PETROLEUM COMPANY (US) 1984-07-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050054858-A1 Facile synthesis of 1,9-diacyldipyrromethanes GLI2, DKC1, NR2F2 CA2 205/4885CA4 1018/4885CA1 1327/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.